i pledge accutane The results may translate into clinical practice by means of therapeutic drug monitoring, which represents a direct and applicable method to identify breast cancer patients with poor tamoxifen metabolism regardless of genotype and inhibiting drug interactions on the CYP enzymes 35
i pledge accutane The results may translate into clinical practice by means of therapeutic drug monitoring, which represents a direct and applicable method to identify breast cancer patients with poor tamoxifen metabolism regardless of genotype and inhibiting drug interactions on the CYP enzymes 35